Prevalence and clinical course of dengue infection in elderly patients with acute febrile illness in a tertiary care hospital in Cali, Colombia

Fernando Rosso, Sara Vanegas, Sarita Rodríguez, Robinson Pacheco, .

Keywords: severe dengue/epidemiology, aged, hospitalization, fever, mortality, Colombia

Abstract

Introduction: Little is known about the prevalence and clinical course of dengue infection in elderly patients living in endemic areas; it is presumed that there is a lower prevalence but higher severity, complications and mortality. Objective: To describe the prevalence and clinical course of dengue infection in elderly patients who were admitted to a referral care center for infectious diseases in an endemic region. Materials and methods: We conducted an observational and descriptive study between 2011 and 2014, using a cohort of elderly patients with serological diagnosis of dengue. Results: A total of 235 febrile elderly patients were assessed, of which 43 patients (18.3%) were found to have dengue. The median age was 71 years; 48.7% were female, and 89% of patients had at least one comorbid condition. According to the serological tests, 51.4% of cases were positive for NS1 Ag, 27% for IgM and 54.1% for IgG, while 64.8% were secondary infections. Dengue was diagnosed in 13 patients (35%), dengue with warning signs in 16 cases (43%), and severe dengue in 8 cases (22%). Nearly 56.7% of patients were admitted to hospital and 21.6%, to the intensive care unit. None died. Conclusion: We found dengue infection to be more frequent than expected in this sample of elderly patients, due to acute febrile syndrome. Elderly patients also required higher rate of hospitalization and had more complications, however there were no deaths due to good management.

Downloads

Download data is not yet available.
  • Fernando Rosso Departamento de Medicina Interna-Infectología, Fundación Clínica Valle del Lili, Cali, Colombia Centro de Investigaciones Clínicas, Fundación Clínica Valle del Lili, Cali, Colombia Departamento de Salud Pública, Facultad de Ciencias de la Salud, Universidad ICESI, Cali, Colombia
  • Sara Vanegas Programa de Medicina, Facultad de Ciencias de la Salud, Universidad ICESI, Cali, Colombia http://orcid.org/0000-0003-2964-3192
  • Sarita Rodríguez Centro de Investigaciones Clínicas, Fundación Clínica Valle del Lili, Cali, Colombia
  • Robinson Pacheco Centro de Investigaciones Clínicas, Fundación Clínica Valle del Lili, Cali, Colombia Departamento de Salud Pública, Facultad de Ciencias de la Salud, Universidad ICESI, Cali, Colombia

References

Weiskopf D, Angelo MA, Sidney J, Peters B, Shresta S, Sette A. Immunodominance changes as a function of the infecting dengue virus serotype and primary versus secondary infection. J Virol. 2014;88:11383-94. http://dx.doi.org/10.1128/JVI.01108-14

Mustafa MS, Rasotgi V, Jain S, Gupta V. Discovery of fifth serotype of dengue virus (DENV-5): A new public health dilemma in dengue control. Med J Armed Forces India. 2014;71:67-70. http://dx.doi.org/10.1016/j.mjafi.2014.09.011

World Health Organization. Dengue: Guidelines for diagnosis, treatment, prevention and control. Geneva: World Health Organization; 2009.

Velandia ML, Castellanos JE. Virus del dengue: estructura y ciclo viral. Infectio. 2011;15:33-43. http://dx.doi.org/10. 1016/S0123-9392(11)70074-1

Kourí G. El dengue, un problema creciente de salud en las Américas. Rev Panam Salud Pública. 2006;19:143-5. http://dx.doi.org/10.1590/S1020-49892006000300001

World Health Organization. Dengue and severe dengue. Fecha de consulta: 9 de abril de 2015. Disponible en: http://www.who.int/mediacentre/factsheets/fs117/en/

Simmons CP, Farrar JJ, Nguyen VV, Wills B. Dengue. N Engl J Med. 2012;366;1423-32. http://dx.doi.org/10.1056/NEJMra1110265

Rosso F, Vélez JD. Dengue. Carta de la Salud. 2013. Fecha de consulta:15 de abril de 2015. Disponible en: http://www.valledellili.org/sites/default/files/files/carta-de-la-salud-marzo-2013.pdf

Instituto Nacional de Salud. Boletín epidemiológico semanal. Semana epidemiológica número 53 de 2014. Fecha de consulta: 15 de abril de 2015. Disponible en: http://www.ins.gov.co/boletin-epidemiologico/Boletn%20Epidemiolgico/2014%20Boletin%20epidemiologico%20semana%2053.pdf

Omran AR. The epidemiologic transition: A theory of the epidemiology of population change. Milbank Q. 2005;83: 731-57. http://dx.doi.org/10.1093/jhmas/jrp058

Halstead SB. Dengue in the health transition. Gaoxiong Yi Xue Ke Xue Za Zhi. 1994;10:S2-14.

Opal SM, Girard TD, Ely EW. The immunopathogenesis of sepsis in elderly patients. Clin Infect Dis. 2005;41:S504-12. http://dx.doi.org/10.1086/432007

Guzmán MG, Harris E. Dengue. Lancet. 2015;385:453-65. http://dx.doi.org/10.1016/S0140-6736(14)60572-9

Pang J, Salim A, Lee VJ, Hibberd ML, Chia KS, Leo YS, et al. Diabetes with hypertension as risk factors for adult dengue hemorrhagic fever in a predominantly dengue serotype 2 epidemic: A case control study. PLoS Negl Trop Dis. 2012;6:e1641. http://dx.doi.org/10.1371/journal.pntd.0001641

García-Rivera EJ, Rigau-Pérez JG. Dengue severity in the elderly in Puerto Rico. Rev Panam Salud Pública. 2003;13:362-8. http://dx.doi.org/10.1590/S1020-498920030 00500004

Liu CC, Huang KJ, Huang MC, Lin JJ, Wang SM, Liu JJ, et al. High case-fatality rate of adults with dengue hemorrhagic fever during an outbreak in non-endemic Taiwan: Risk factors for dengue-infected elders. Am J Infect Dis. 2008;4: 10-7. http://dx.doi.org/ 10.3844/ajidsp.2008.10.17

Sam SS, Omar SF, Teoh BT, Abd-Jamil J, AbuBakar S. Review of dengue hemorrhagic fever fatal cases seen among adults: A retrospective study. PLoS Negl Trop Dis. 2013;7:1-7. Http://dx.doi.org/10.1371/journal.pntd.0002194

Lye DC, Lee VJ, Sun Y, Leo YS. The benign nature of acute dengue infection in hospitalized older adults in Singapore. Int J Infect Dis. 2010;14:e410-3. http://dx.doi.org/10.1016/j.ijid.2009.06.026

Rowe EK, Leo YS, Wong JGX, Thein TL, Gan VC, Lee LK, et al. Challenges in dengue fever in the elderly: A typical presentation and risk of severe dengue and hospital-acquired infection. PLoS Negl Trop Dis. 2014;8:e2886. http://dx.doi.org/10.1371/journal.pntd.0002777

Leo YS, Thein TL, Fisher DA, Low JG, Oh HM, Narayanan RL, et al. Confirmed adult dengue deaths in Singapore: 5-year multi-center retrospective study. BMC Infect Dis. 2011;11:123. http://dx.doi.org/10.1186/1471-2334-11-123

Lee IK, Liu JW, Yang KD. Clinical and laboratory charac-teristics and risk factors for fatality in elderly patients with dengue hemorrhagic fever. Am J Trop Med Hyg. 2008;79:149-53.

Guzmán MG, Kourí G, Bravo J, Valdés L, Susana V, Halstead SB. Effect of age on outcome of secondary dengue 2 infections. Int J Infect Dis. 2002;6:118-24. http://dx.doi.org/10.1016/S1201-9712(02)90072-X

Doggett DL, Chang MP, Makinodan T, Strehler B. Cellular and molecular aspects of immune system aging. Mol Cell Biochem. 1981;37:137-56. http://dx.doi.org/10.1007/BF02354883

Mathew A, Kurane I, Green S, Vaughn DW, Kalayanarooj S, Suntayakorn S, et al. Impaired T cell proliferation in acute dengue infection. J Immunol. 1999;162:5609-15.

Lee IK, Liu JW, Yang KD. Clinical characteristics and risk factors for concurrent bacteremia in adults with dengue hemorrhagic fever. Am J Trop Med Hyg. 2005;72:221-6.

Kuo CH, Tai DI, Chang-Chien CS, Lan CK, Chiou SS, Liaw YF. Liver biochemical tests and dengue fever. Am J Trop Med Hyg.1992;47:265-70.

Kalayanarooj S, Vaughn DW, Nimmannitya S, Green S, Suntayakorn S, Kunentrasai N, et al. Early clinical and laboratory indicators of acute dengue illness. J Infect Dis.1997;176:313-21. http://dx.doi.org/10.1086/514047

Tan SS, Bujang MA. The clinical features and outcomes of acute liver failure associated with dengue infection in adults: A case series. Braz J Infect Dis. 2013;17:164-9. http://dx.doi.org/10.1016/j.bjid.2012.09.007

Villar-Centeno LA, Lozano-Parra A, Salgado-García D, Herrán OF. Alteraciones bioquímicas como marcadores predictores de gravedad en pacientes con fiebre por dengue. Biomédica. 2013;33(Supl.1):63-9. http://dx.doi.org/10.7705/biomedica.v33i0.732

Avirutnan P, Punyadee N, Noisakran S, Komoltri C, Thiemmeca S, Auethavornanan K, et al. Vascular leakage in severe dengue virus infections: A potential role for the nonstructural viral protein NS1 and complement. J Infect Dis. 2006;193:1078-88. http://dx.doi.org/ 10.1086/500949

Libraty DH, Young PR, Pickering D, Endy TP, Kalayanarooj S, Green S, et al. High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever. J Infect Dis. 2002;186:1165-8. http://dx.doi.org/10.1086/343813

Schlesinger JJ. Flavivirus nonstructural protein NS1: Complementary surprises. Proc Natl Acad Sci USA. 2006; 103:18879-80. http://dx.doi.org/10.1073/pnas.0609522103

Juneja D, Nasa P, Singh O, Javeri Y, Uniyal B, Dang R. Clinical profile, intensive care unit course, and outcome of patients admitted in intensive care unit with dengue. J Crit Care. 2011;26:449-52. http://dx.doi.org/10.1016/j.jcrc. 2011.05.007

Murgue B, Deparis X, Chungue E, Cassar O, Roche C. Dengue: An evaluation of dengue severity in French Polynesia based on an analysis of 403 laboratory-confirmed cases. Trop Med Int Heal. 1999;4:765-73. http://dx.doi.org/10.1046/j.1365-3156.1999.00478.x

Wang CC, Lee IK, Su MC, Lin HI, Huang YC, Liu SF, et al. Differences in clinical and laboratory characteristics and disease severity between children and adults with dengue virus infection in Taiwan, 2002. Trans R Soc Trop Med Hyg. 2009103:871-7. http://dx.doi.org/10.1016/j.trstmh. 2009.04.024

Anders KL, Nguyet NM, Chau NVV, Hung NT, Thuy TT, Lien LB, et al. Epidemiological factors associated with dengue shock syndrome and mortality in hospitalized dengue patients in Ho Chi Minh City, Vietnam. Am J Trop Med Hyg. 2011;84:127-34. http://dx.doi.org/10.4269/ajtmh. 2011.10-0476

Rico-Hesse R, Harrison LM, Salas RA, Tovar D, Nisalak A, Ramos C, et al. Origins of dengue type 2 viruses associated with increased pathogenicity in the Americas. Virology. 1997;230:244-51. http://10.1006/viro.1997.8504

Wichmann O, Hongsiriwon S, Bowonwatanuwong C, Chotivanich K, Sukthana Y, Pukrittayakamee S. Risk factors and clinical features associated with severe dengue infection in adults and children during the 2001 epidemic in Chonburi, Thailand. Trop Med Int Health. 2004;9:1022-9. http://dx.doi.org/10.1111/j.1365-3156.2004.01295.x

Ranjit S, Kissoon N. Dengue hemorrhagic fever and shock syndromes. Pediatr Crit Care Med. 2011;12:90-100. http://dx.doi.org/10.1097/PCC.0b013e3181e911a7

Hammond SN, Balmaseda A, Pérez L, Téllez Y, Saborío SI, Mercado JC, et al. Differences in dengue severity in infants, children, and adults in a 3-year hospital-based study in Nicaragua. Am J Trop Med Hyg. 2005;73:1063-70.

Nikin-Beers R, Ciupe SM. The role of antibody in enhancing dengue virus infection. Math Biosci. 2015;263:83-92. http://dx.doi.org/10.1016/j.mbs.2015.02.004

Whitehead SS, Blaney JE, Durbin AP, Murphy BR. Prospects for a dengue virus vaccine. Nat Rev Microbiol. 2007;5:518-28. http://dx.doi.org/10.1038/nrmicro1690

Mongkolsapaya J, Dejnirattisai W, Xu X, Vasanawathana S, Tangthawornchaikul N, Chairunsri A, et al. Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat Med. 2003;9:921-7. http://dx.doi.org/10.1038/nm887

How to Cite
1.
Rosso F, Vanegas S, Rodríguez S, Pacheco R. Prevalence and clinical course of dengue infection in elderly patients with acute febrile illness in a tertiary care hospital in Cali, Colombia. biomedica [Internet]. 2016 Aug. 1 [cited 2024 May 18];36(Sup2):179-86. Available from: https://revistabiomedica.org/index.php/biomedica/article/view/2961

Some similar items:

Published
2016-08-01

Altmetric

Article metrics
Abstract views
Galley vies
PDF Views
HTML views
Other views
QR Code